The University of Florida Health Cancer Center has been selected as one of 12 initial clinical trial sites participating in Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer. An initiative of the national nonprofit organization Pancreatic Cancer Action Network, Precision Promise was announced Oct 4. Click here to read more!